Michelle L Stewart

This inventor holds 10 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Dana-Farber-Cancer Institute Inc., Vertex Pharmaceuticals, Inc.. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michelle L Stewart. Retrieved from https://idiyas.com/inventor/michelle-l-stewart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 2)

% Patents Active = 50.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 57(Granted Patents)

Location History:

Somerville, MA (US) (2014)
Brookline, MA (US) (2011 - 2018)
Cambridge, MA (US) (2010 - 2021)

Company Filing History:

6 out of 1,268

Dana-Farber-Cancer Institute Inc.

patents

4 out of 1,167

Vertex Pharmaceuticals, Inc.

patents

Years Active: 2010-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12528846 - BH4 Stabilized Peptides And Uses Thereof (2026-01-20),

2. 11046739 - BH4 stabilized peptides and uses thereof (2021-06-29),

3. 10106590 - BH4 stabilized peptides and uses thereof (2018-10-23),

4. 10000511 - Small molecules for the modulation of MCL-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders (2018-06-19),

5. 9505816 - Methods and compositions for specific modulation of MCL-1 (2016-11-29),

6. 9079970 - Methods and compositions for specific modulation of MCL-1 (2015-07-14),

7. 8937064 - Pyrazolo[1,5-a]pyrimidines useful as JAK2 inhibitors (2015-01-20),

8. 8921376 - Pyrrolopyridines useful as inhibitors of protein kinase (2014-12-30),

9. 7998987 - Inhibitors of c-Met and uses thereof (2011-08-16),

10. 7728017 - Inhibitors of c-Met and uses thereof (2010-06-01),

Title: Michelle L Stewart: Innovator in BH4 Stabilized Peptides

Introduction

Michelle L Stewart is a prominent inventor based in Brookline, MA, known for her significant contributions to the field of biochemistry and molecular biology. With a total of nine patents to her name, she has made remarkable advancements in the development of polypeptides that have potential therapeutic applications.

Latest Patents

Among her latest patents is the invention of BH4 stabilized peptides and their uses. These polypeptides contain stabilized BH4 domains of BCL-2 family proteins, which are capable of binding, inactivating, and modulating BAX protein, along with its close homologues BAK and BOK. The patents also describe compositions that include these polypeptides and methods for treating cytotoxic diseases by administering these innovative polypeptides to subjects.

Career Highlights

Michelle has worked with esteemed organizations such as Dana-Farber Cancer Institute Inc. and Vertex Pharmaceuticals, Inc. Her work in these institutions has allowed her to further her research and contribute to significant advancements in cancer treatment and molecular therapies.

Collaborations

Some of her notable coworkers include Loren D Walensky and Jon H Come, who have collaborated with her on various projects, enhancing the impact of her research in the scientific community.

Conclusion

Michelle L Stewart's innovative work in the field of stabilized peptides showcases her dedication to advancing medical science. Her contributions have the potential to lead to new treatments for cytotoxic diseases, making her a key figure in her field.

Profile summary based on public USPTO records.